Visit us at DCAT

dcat-full-new-20220303171738.jpg

March, 2022

Galenicum visits New York during DCAT Week

After Galenicum's attendance at the CPhI in Milano last month of November, it is time for new pharma events, and Galenicum is proud to announce its presence at the next DCAT Week.

"DCAT Week is the premier global event held annually in New York City for companies engaged in the Bio/Pharmaceutical manufacturing value chain. It is not a Trade Show, it is a multifaceted event where DCAT Member Companies have the opportunity to reserve meeting space through the DCAT organization to conduct high-level, private, strategic meetings with customers and suppliers."

During one week, Galenicum will be attending DCAT Week in New York City from 21st to 24th of March to present its updated FDF portfolio for the US market, and potentially open new opportunities that the American market can offer.

Are you willing to meet any of our representatives at the event? Do not hesitate to contact us at hello@galenicum.com

See you in New York City!

Thanks for reaching out. We will get back to you as soon as possible.

RESTRICTED ACCESS

The information contained in this section is aimed at the healthcare professional of the Pharmaceutical Industry, therefore, specialized training is required for its correct interpretation.

The products mentioned may have a different authorized data sheet in each country.

If you click the "accept" button, you are expressing your willingness to access the information explicitly intended for healthcare professionals.

DABIGAMAX

DEVELOPMENT OF THE FIRST GENERIC PHARMACEUTICAL SPECIALTY WITH DABIGATRAN. Decision EMC/2755/2017, dated November 20, (DOGC núm. 7508 of 30/11/2017) regarding the call for NUCLEUS OF INDUSTRIAL RESEARCH AND EXPERIMENTAL DEVELOPMENT (file number RD17-1-0006). This project has received funding from the European Union through the European Regional Development Fund (ERDF). With the collaboration from ACCIÓ.